ID   SMKT-R4
AC   CVCL_A752
SY   SMKT-R-4; SMKTR4
DR   Wikidata; Q54954965
RX   PubMed=1433606;
RX   PubMed=2051699;
RX   PubMed=8620516;
RX   PubMed=27993170;
CC   Population: Japanese.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   44Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 12
//
RX   PubMed=1433606; DOI=10.1016/S0022-5347(17)37026-X;
RA   Tsukamoto T., Kumamoto Y., Miyao N., Masumori N., Takahashi A.,
RA   Yanase M.;
RT   "Interleukin-6 in renal cell carcinoma.";
RL   J. Urol. 148:1778-1782(1992).
//
RX   PubMed=2051699; DOI=10.5980/jpnjurol1989.82.613;
RA   Otani N., Tsukamoto T., Kumamoto Y., Miyao N.;
RT   "Study on in vitro invasive potential of renal cell carcinoma cell
RT   lines and effect of growth factors (EGF and TGF-beta 1) on their in
RT   invasions.";
RL   Nihon Hinyokika Gakkai Zasshi 82:613-619(1991).
//
RX   PubMed=8620516;
RA   Satoh M., Handa K., Saito S., Tokuyama S., Ito A., Miyao N.,
RA   Orikasa S., Hakomori S.-i.;
RT   "Disialosyl galactosylgloboside as an adhesion molecule expressed on
RT   renal cell carcinoma and its relationship to metastatic potential.";
RL   Cancer Res. 56:1932-1938(1996).
//
RX   PubMed=27993170; DOI=10.1186/s12943-016-0565-8; PMCID=PMC5168717;
RA   Brodaczewska K.K., Szczylik C., Fiedorowicz M., Porta C.,
RA   Czarnecka A.M.;
RT   "Choosing the right cell line for renal cell cancer research.";
RL   Mol. Cancer 15:83.1-83.15(2016).
//